Bard (company)
Pharmaceutical company / From Wikipedia, the free encyclopedia
Dear Wikiwand AI, let's keep it short by simply answering these key questions:
Can you list the top facts and stats about Bard (company)?
Summarize this article for a 10 year old
C. R. Bard, Inc., headquartered in Murray Hill, New Jersey, USA, was a developer, manufacturer, and marketer of medical technologies in the vascular medicine, urology, oncology, and surgical specialty fields. C. R. Bard marketed its products and services worldwide to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. An S&P 500 company with approximately 14,000 employees in 2015, Bard is perhaps best known for having introduced the Foley catheter in 1934.[citation needed]
![]() | |
Company type | Subsidiary |
---|---|
Founded | 1907 |
Founder | Charles Russell Bard |
Headquarters | New Providence, New Jersey, U.S. |
Area served | Worldwide |
Key people | Timothy M. Ring (Chairman) & (CEO) |
Products | Vascular, Urology, Oncology, and Surgical Specialties |
Revenue | ![]() |
![]() | |
![]() | |
Total assets | ![]() |
Total equity | ![]() |
Number of employees | 14,000 (2015)[3] |
Parent | Becton, Dickinson and Company |
In April 2017, C. R. Bard announced that it would be acquired by Becton, Dickinson and Company (BD).[4][self-published source] The transaction was completed later that year,[5] and the company became a wholly-owned subsidiary of BD, rebranded as Bard.